Abstract
Background and Aims
Pancreatic adenocarcinoma is the fourth leading cause of cancer-related death in the United States. Pancreatic cancer is diagnosed in some patients by endoscopic ultrasonography (EUS) even in the absence of an obvious mass lesion on transabdominal imaging studies. The purpose of this study was to estimate the prevalence of PBM on EUS-FNA in patients with no obvious mass on transabdominal imaging and identify possible predictors of PBM in this cohort of patients.
Methods
Three hundred and twenty-six patients (219 female; mean age: 57) with no obvious neoplastic lesion on trans-abdominal imaging underwent EUS. Demographic data, indication of EUS, history of weight loss, smoking, alcohol use, diabetes, cholecystectomy status, CT and USG findings, and liver function tests (LFTs) were reviewed.
Results
Thirty patients (9%) were diagnosed with a PBM by EUS-FNA (27 pancreatic adenocarcinoma, three ampullary adenocarcinoma). The mean age of patients diagnosed with PBM was significantly (P < 0.01) higher than controls. The mean size of the tumor was 2.8 cm (range: 0.9–7 cm). Male gender, presence of jaundice, abnormal LFTs, weight loss, and nonspecific trans-abdominal imaging results such as dilated common bile duct (CBD), and abnormal appearing pancreas predicted the presence (P < 0.05) of PBM, whereas patients with previous cholecystectomy and abdominal pain were less likely to have this diagnosis.
Conclusions
Normal trans-abdominal imaging does not completely exclude the presence of PBM. Nonspecific pancreatic abnormalities and CBD dilation on trans-abdominal imaging, with jaundice, abnormal LFTs, weight loss, and lack of abdominal pain are predictors of PBM.
Similar content being viewed by others
References
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–249.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.
Wilson LS, Lightwood JM. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol. 1999;71:171–181.
Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg. 1995;221:721–731. discussion 731–723.
Wray CJ, Ahmad SA, Matthews JB, Lowy AM. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626–1641.
Dewitt J, Devereaux BM, Lehman GA, Sherman S, Imperiale TF. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4:717–725. quiz 664.
Jemaa Y, Houissa F, Trabelsi S, et al. Endoscopic ultrasonography versus helical CT in diagnosis and staging of pancreatic cancer. Tunis Med. 2008;86:346–349.
Agarwal B, Abu-Hamda E, Molke KL, Correa AM, Ho L. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol. 2004;99:844–850.
Songur Y, Temucin G, Sahin B. Endoscopic ultrasonography in the evaluation of dilated common bile duct. J Clin Gastroenterol. 2001;33:302–305.
Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI. EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest Endosc. 2008;68:237–242. quiz 334, 335.
Ho S, Bonasera RJ, Pollack BJ, Grendell J, Feuerman M, Gress F. A single-center experience of endoscopic ultrasonography for enlarged pancreas on computed tomography. Clin Gastroenterol Hepatol. 2006;4:98–103.
Singh S, Reddymasu S, Waheed S, et al. Endoscopic ultrasonography findings in patients with non-specific changes of the pancreas on computed tomography: a single-center experience. Dig Dis Sci. 2008;53:2799–2804.
Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg. 1990;211:447–458.
Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68–72. discussion 72-63.
Kauhanen SP, Komar G, Seppanen MP, et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg. 2009;250:957–963.
Iglesias Garcia J, Larino Noia J, Dominguez Munoz JE. Endoscopic ultrasound in the diagnosis and staging of pancreatic cancer. Rev Esp Enferm Dig. 2009;101:631–638.
Papanikolaou IS, Adler A, Neumann U, Neuhaus P, Rosch T. Endoscopic ultrasound in pancreatic disease–its influence on surgical decision-making. An update 2008. Pancreatology. 2009;9:55–65.
Akdogan M, Sasmaz N, Kayhan B, Biyikoglu I, Disibeyaz S, Sahin B. Extraordinarily elevated CA19–9 in benign conditions: a case report and review of the literature. Tumori. 2001;87:337–339.
Clave P, Boadas J, Gonzalez-Carro P, et al. Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer. Gastroenterol Hepatol. 1999;22:335–341.
Ulla Rocha JL, Alvarez Sanchez MV, Paz Esquete J, et al. Evaluation of the bilio-pancreatic region using endoscopic ultrasonography in patients referred with and without abdominal pain and CA 19–9 serum level elevation. JOP. 2007;8:191–197.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Syed Faisal Jafri and Shailender Singh contributed to the research when they were affiliated with Kansas University Medical Center.
Rights and permissions
About this article
Cite this article
Reddymasu, S.C., Gupta, N., Singh, S. et al. Pancreato-Biliary Malignancy Diagnosed by Endoscopic Ultrasonography in Absence of a Mass Lesion on Transabdominal Imaging: Prevalence and Predictors. Dig Dis Sci 56, 1912–1916 (2011). https://doi.org/10.1007/s10620-010-1511-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1511-z